These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 37307215)

  • 1. Exploring the complex and multifaceted interplay of the gut microbiome and cancer prevention and therapy.
    Kashyap S; Das A
    Acta Microbiol Immunol Hung; 2023 Jun; 70(2):85-99. PubMed ID: 37307215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy.
    Brenchley JM; Serrano-Villar S
    Microbiome; 2024 Jun; 12(1):113. PubMed ID: 38907315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiome's Universe: Impact on health, disease and cancer treatment.
    Réthi-Nagy Z; Juhász S
    J Biotechnol; 2024 Sep; 392():161-179. PubMed ID: 39009231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplantation in cancer management: Current status and perspectives.
    Chen D; Wu J; Jin D; Wang B; Cao H
    Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic-associated Gut Dysbiosis.
    Ramakrishna BS; Patankar R
    J Assoc Physicians India; 2023 Nov; 71(11):62-68. PubMed ID: 38720499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota: a potential target for improved cancer therapy.
    Zhao M; Jiang G; Zhou H; Li J; Xiang W; Li S; Wang H; Zhou J
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):541-552. PubMed ID: 36550389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities of therapeutic manipulation of the gut microbiota].
    Drastich P; Bajer L; Kverka M
    Vnitr Lek; 2018; 64(6):665-671. PubMed ID: 30223665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment.
    Xu H; Cao C; Ren Y; Weng S; Liu L; Guo C; Wang L; Han X; Ren J; Liu Z
    Front Immunol; 2022; 13():949490. PubMed ID: 36177041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
    Lau HCH; Sung JJ; Yu J
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome and its clinical implications: exploring the key players in human health.
    Koneru S; Thiruvadi V; Ramesh M
    Curr Opin Infect Dis; 2023 Oct; 36(5):353-359. PubMed ID: 37593952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of gut microbiota and probiotics in preventing, treating, and boosting the immune system in colorectal cancer.
    Masheghati F; Asgharzadeh MR; Jafari A; Masoudi N; Maleki-Kakelar H
    Life Sci; 2024 May; 344():122529. PubMed ID: 38490297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Link between Gut Microbiota and Hepatic Encephalopathy.
    Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
    Elangovan A; Allegretti JR; Fischer M
    Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases.
    Han Z; Min Y; Pang K; Wu D
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.
    Ting NL; Lau HC; Yu J
    Gut; 2022 Jul; 71(7):1412-1425. PubMed ID: 35277453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Human Gut Microbiome as a Potential Factor in Autism Spectrum Disorder.
    Alharthi A; Alhazmi S; Alburae N; Bahieldin A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human gut microbiota/microbiome in health and diseases: a review.
    Gomaa EZ
    Antonie Van Leeuwenhoek; 2020 Dec; 113(12):2019-2040. PubMed ID: 33136284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervention on gut microbiota may change the strategy for management of colorectal cancer.
    Taghinezhad-S S; Mohseni AH; Fu X
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1508-1517. PubMed ID: 33295040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.